Atlas Logo
Large-scale real-world data analysis identifies comorbidity patterns in schizophrenia
BACK
Sample details

This study aimed to systematically identify comorbidity patterns associated with schizophrenia using large-scale real-world health insurance data. The cohort comprised 86 million individuals enrolled in Aetna employer-sponsored health insurance plans across the United States of America, with data collected retrospectively from 2008 to 2019. The cohort included individuals aged 15 years or older who were diagnosed with schizophrenia, as well as matched controls. Follow-up occurred continuously during each participant’s insurance coverage, with an average observation period of around six years.

Study design
Cohort

Number of participants at first data collection

86,000,000 (participants)

Age at first data collection

≥ 15 years (participants)

Participant year of birth

Varied (participants)

Participant sex
All

Representative sample at baseline?
No

Sample features

Adults
Control participants
People with psychiatric conditions
Young people
Dataset details

Country

United States of America

Year of first data collection

2008

Primary Institutions

Harvard Medical School (HMS)

Massachusetts General Hospital (MGH)

Massachusetts Institute of Technology (MIT)

Links
No website available

Profile paper DOI

doi.org/10.1038/s41398-022-01916-y

Funders

Blavatnik Center for Computational Biomedicine Award

National Institute of General Medical Sciences (NIGMS)

Ongoing?
No

Data types collected

mentalHealthData
dataLinkage
Quantitative data collection
  • Secondary data
Qualitative data collection
  • None
Neuroimaging data collection
  • None
Linked or secondary data
  • Healthcare data
Features

Engagement

  • None
  • Keywords

    Comorbidity
    Diagnostic information
    Health insurance
    Mental health
    Mental health outcomes
    Prescriptions
    Schizophrenia
    Contact us

    |

    FAQS

    |

    Privacy

    |

    © 2024 Louise Arseneault

    Platform by Delosis